Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Bodey, B
   Genetically engineered antibodies for direct antineoplastic treatment and systematic delivery of various therapeutic agents to cancer cells
   EXPERT OPINION ON BIOLOGICAL THERAPY
   
   B. Bodey, "Genetically engineered antibodies for direct antineoplastic treatment and systematic delivery of various therapeutic agents to cancer cells", EXPERT OP B, 1(4), 2001, pp. 603-617
2. DELVIG AA; WEDEGE E; CAUGANT DA; DALSEG R; KOLBERG J; ACHTMAN M; ROSENQVIST E
   A LINEAR B-CELL EPITOPE AN THE CLASS-3 OUTER-MEMBRANE PROTEIN OF NEISSERIA-MENINGITIDIS RECOGNIZED AFTER VACCINATION WITH THE NORWEGIAN GROUP-B OUTER-MEMBRANE VESICLE VACCINE
   Microbiology
   
   A.A. Delvig et al., "A LINEAR B-CELL EPITOPE AN THE CLASS-3 OUTER-MEMBRANE PROTEIN OF NEISSERIA-MENINGITIDIS RECOGNIZED AFTER VACCINATION WITH THE NORWEGIAN GROUP-B OUTER-MEMBRANE VESICLE VACCINE", Microbiology, 141, 1995, pp. 1593-1600
3. PARHAMISEREN B; LYNCH M; WHITE HD; REED GL
   MAPPING THE ANTIGENIC REGIONS OF STREPTOKINASE IN HUMANS BEFORE AND AFTER STREPTOKINASE THERAPY
   Molecular immunology
   
   B. Parhamiseren et al., "MAPPING THE ANTIGENIC REGIONS OF STREPTOKINASE IN HUMANS BEFORE AND AFTER STREPTOKINASE THERAPY", Molecular immunology, 32(10), 1995, pp. 717-724